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ABSTRACT
Objectives: National dietary guidelines were
introduced in 1977 and 1983, by the US and UK
governments, respectively, with the ambition of
reducing coronary heart disease (CHD) by reducing fat
intake. To date, no analysis of the evidence base for
these recommendations has been undertaken. The
present study examines the evidence from randomised
controlled trials (RCTs) available to the US and UK
regulatory committees at their respective points of
implementation.
Methods: A systematic review and meta-analysis were
undertaken of RCTs, published prior to 1983, which
examined the relationship between dietary fat, serum
cholesterol and the development of CHD.
Results: 2467 males participated in six dietary trials:
five secondary prevention studies and one including
healthy participants. There were 370 deaths from all-
cause mortality in the intervention and control groups.
The risk ratio (RR) from meta-analysis was 0.996
(95% CI 0.865 to 1.147). There were 207 and 216
deaths from CHD in the intervention and control
groups, respectively. The RR was 0.989 (95% CI 0.784
to 1.247). There were no differences in all-cause
mortality and non-significant differences in CHD
mortality, resulting from the dietary interventions.
The reductions in mean serum cholesterol levels were
significantly higher in the intervention groups; this did
not result in significant differences in CHD or all-cause
mortality. Government dietary fat recommendations
were untested in any trial prior to being introduced.
Conclusions: Dietary recommendations were
introduced for 220 million US and 56 million UK
citizens by 1983, in the absence of supporting
evidence from RCTs.
INTRODUCTION
US public health dietary advice was
announced by the Select Committee on
Nutrition and Human needs in 19771 and
was followed by UK public health dietary
advice issued by the National Advisory
Committee on Nutritional Education in
1983.2 The dietary recommendations in both
cases focused on reducing dietary fat intake;
speciﬁcally to (1) reduce overall fat con-
sumption to 30% of total energy intake and
(2) reduce saturated fat consumption to 10%
of total energy intake.
The recommendations were an attempt to
address the incidence of coronary heart
disease (CHD). Both documents acknowl-
edged that the evidence was not conclusive.
Hegsted’s introduction to the Dietary Goals
for the US noted “there will undoubtedly be
many people who will say we have not proven
our point.”1 The UK publication referred to “a
strong consensus of opinion.”2
KEY MESSAGES
What is already known about this subject?
▸ Dietary recommendations were introduced in the
US (1977) and in the UK (1983) to (1) reduce
overall fat consumption to 30% of total energy
intake and (2) reduce saturated fat consumption
to 10% of total energy intake.
What does this study add?
▸ No randomised controlled trial (RCT) had tested
government dietary fat recommendations before
their introduction. Recommendations were made
for 276 million people following secondary
studies of 2467 males, which reported identical
all-cause mortality. RCT evidence did not support
the introduction of dietary fat guidelines.
How might this impact on clinical practice?
▸ Clinicians may be more questioning of dietary
guidelines, less accepting of low-fat advice (con-
comitantly high carbohydrate) and more
engaged in nutritional discussions about the
role of food in health.
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The evidence available to dietary committees at that
time comprised epidemiological studies and randomised
controlled trials (RCTs). The most comprehensive popu-
lation study undertaken was the Seven Countries Study
by Keys.3 This reported that CHD ‘tended to be related’
to serum cholesterol values and that, these in turn
‘tended to be related’ to the proportion of calories pro-
vided by saturated fats in the diet.4 Keys acknowledged
that epidemiological studies could reveal relationships,
not causation.3 RCTs provide the best evidence.5
While the UK nutritional guidelines2 made reference to
the Seven Countries Study, the US committee document1
did not. Neither publication made reference to any of the
RCTs available at that time. However, the US Committee
report reported data from the non-randomised, cross-over
trial, the Finnish Mental Hospital Study.6 7
Although a number of reviews of RCTs have been
undertaken,8–10 no review has examined the RCT evi-
dence available at the time dietary fat guidelines were
introduced. Furthermore, these guidelines have not been
changed since they had been announced; correspond-
ingly, the validity of their evidence base remains relevant.
This systematic review and meta-analysis will assess if
the published RCTs available to the dietary committees
supported their recommendations on dietary fat. With
this in mind, we hypothesised that RCT evidence avail-
able to the dietary committees at the time of issuing
recommendations did not support the contention that
reducing dietary fat intake would contribute to a reduc-
tion in CHD risk or related mortality.
METHODS
A systematic review and meta-analysis was conducted in
accordance with the PRISMA guidelines.11
Search strategy
A search was undertaken to identify RCTs that examined
the relationship between dietary fat, serum cholesterol
and mortality. Exclusion criteria were: study being obser-
vational; non-randomised and/or multifactorial in
design. Inclusion criteria were: randomised dietary inter-
vention studies; study hypothesis relating to a reduction
or modiﬁcation of dietary fat or cholesterol; participants
were human adults; study was a minimum of 1 year in
duration; data on all-cause mortality, CHD mortality and
cholesterol measurements were available.
Searches were performed of the literature to 1983
using MEDLINE and the Cochrane Library. The AMED,
CAB abstracts, CINAHL, EMBASE, HMIC and SIGLE
(grey literature sources) were not relied on, as their
periods covered were not compatible: from 1985, 1973,
1981, 1980, 1983 and 1992, respectively.12 13 (ﬁgure 1).
Selection of studies
Of the 98 identiﬁed articles, 80 were rejected on review
of the title and abstract. The remaining 18 papers
covered 8 trials, once duplication was resolved. Six RCTs
met the inclusion criteria: Rose Corn Oil Trial;14
Research Committee Low-fat Diet;15 MRC Soya-bean
Oil;16 LA Veterans Study;17 Oslo Diet Heart Study18 19;
and The Sydney Diet Heart Study.20 The Anti-Coronary
club trial21 and The Finnish Mental Hospital Study6 7
were excluded, as they were not randomised. The
Finnish study was also a cross-over trial. This is not
appropriate for the examination of a long-term mortal-
ity, as deaths in the second phase may be due to condi-
tions imposed during the initial phase. Inclusion criteria
are in agreement with previous literature.9
To ascertain the validity of eligible randomised trials, a
pair of reviewers (ZH and FG) worked independently to
determine which studies met the inclusion criteria. The
same six were agreed on. Risk of bias was further
assessed using the PEDro scale for the relative quality of
studies.22 Additionally, the meta-analyses for all-cause
mortality (ﬁgure 2) and CHD deaths (ﬁgure 3) were
tested for sensitivity analysis of the exclusion of any one
study.
Data extraction
Table 1 details data extraction including: study name,
duration, year of publication and conﬁrmation of study
design; participant characteristics; details of intervention
and comparison diet; and outcomes relating to all-cause
mortality, CHD-related deaths and changes in mean
serum cholesterol levels. Where a study contained more
than one intervention, both were included.14
Statistical analysis
The overall pooled effect was calculated using random
effects meta-analysis. Heterogeneity was evaluated using
the Q-value, I2 and T2 calculations. Funnel plot method-
ology24 and Egger’s regression intercept23 24 have been
calculated, noting the caution for analysing publication
bias using funnel plot asymmetry where the
meta-analysis has fewer than 10 studies.25 Analyses were
performed using Comprehensive Meta-Analysis.26
RESULTS
Participants and study design
The identiﬁed RCTs included a total of 740 deaths and
423 deaths from CHD among 2467 male participants
(table 1). All but one trial exclusively studied secondary
prevention participants. The LA Veterans Study17 com-
prised one-ﬁfth secondary participants and four-ﬁfths
primary participants.
All trials were parallel and randomised. Two were
blinded for outcome assessment.15 16 Two were open,
with no blinding on either side.19 20 The LA Veterans
study17 was reported as double blinded, but the dietary
changes were so substantial that this seems implausible
(egg consumption quantiﬁed, vegetable oils added and
animal fats restricted). Rose et al14 was reported as
blinded to intervention participants for the type of oil,
but not blinded for outcome assessment.
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The mean duration of the six trials was 5.4±3.5 years.
The weighted mean (person years by people) was 6.5
±1 years.
Quality scores were moderate and relatively homogen-
ous: all trials had quality scores of 4 or 5 using the
PEDro scale.22 The meta-analyses for all-cause mortality
(ﬁgure 2) and CHD deaths (ﬁgure 3) were tested for
sensitivity analysis of the exclusion of any one study.
There were no circumstances in which the exclusion of
any one study made the overall effect size signiﬁcant.
Statistical evidence for substantial between study het-
erogeneity was not found. For all deaths, the Q-value was
7.115 (6° of freedom). I2 was 15.676 and T2 was 0.006.
For CHD deaths, the Q-value was 8.649 (6° of freedom).
I2 was 30.632 and T2 was 0.028.
Visual inspection of the funnel plots revealed that none
of the studies lay outside the SE funnel for the
meta-analysis of all deaths or CHD deaths. The two, small,
Rose et al14 studies produced asymmetry on the lower right
hand side of the funnels. Egger’s regression test conﬁrmed
some asymmetry, noting the caution for the small number
of studies.25 The Egger’s regression intercept was 1.029
(95% CI two-tailed, −0.433 to 2.492) (one-tailed p=0.065;
two-tailed p=0.130) for the all deaths meta-analysis and
1.554 (95% CI two-tailed, −0.013 to 3.121) (one-tailed
p=0.025; two-tailed p=0.051) for CHD deaths.
Interventions and comparisons
Five of the six RCTs did not examine either a total fat
consumption of 30%, or a saturated fat consumption of
Figure 1 Summary of systematic review profile.11
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10%, of energy intake. The trials examined: the adminis-
tration of vegetable oil;14 16 17 19 the replacement of
saturated fats with vegetable oil;16 17 19 and an approxi-
mate 20% fat diet.15 A single RCT20 examined the con-
sequence of a 10% saturated fat diet and reported a
higher incidence of all-cause mortality and CHD deaths
in the intervention group.
Outcomes: all-cause mortality
Across six studies containing seven dietary interven-
tions14 involving 1227 people in the intervention groups
and 1240 people in the control groups, there were 370
deaths in the intervention and control groups. The all-
cause mortality was 30.2% in the intervention groups
and 29.8% in the control groups.
The mean death rate was high reﬂecting the fact that
these were secondary prevention studies, except for the
combined primary and secondary prevention LA
Veterans study. Unsurprisingly death rates were higher
in the longer term studies. The lowest death rate was
observed in the control group of Rose et al.14
In the meta-analysis of all-cause mortality, the LA
Veterans study17 carried the greatest weight, 41.71%,
(ﬁgure 2 random effects methodology). The corn and
olive oil interventions had negligible impact on the overall
effect, with weights of 0.46% and 0.41%, respectively.14
The risk ratio (RR) for all seven studies was 0.996 (95% CI
0.865 to 1.147). The overall effect measurement lies on
the line of no effect. There was no statistically signiﬁcant
relationship between dietary interventions and all-cause
mortality.
Figure 2 Estimates of total mortality (95% CIs) from meta-analysis.
Figure 3 Estimates of CHD mortality (95% CIs) from meta-analysis.
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CHD mortality
The seven interventions recorded 207 deaths from CHD
in the intervention groups and 216 in the control
groups. The forest plot for the dietary interventions and
deaths from CHD produced the meta-analysis is shown
in ﬁgure 3 (random effects methodology).
In the meta-analysis of CHD mortality, the Leren Oslo
study19 carried the greatest weight, 34.16%, (ﬁgure 3
random effects methodology). The corn and olive oil
interventions carried the least weight with 1.22% and
1.09%, respectively.14 The RR for all seven studies was
0.989 (95% CI 0.784 to 1.247). The overall effect measure-
ment lies on the line of no effect. There was no statistically
signiﬁcant relationship between dietary interventions and
heart deaths.
Significance reported by the studies
Three studies15–17 and the olive oil14 intervention
reported no signiﬁcant differences in deaths. The corn
oil deaths were reported as signiﬁcantly different, in
favour of the control group (0.1>p>0.05).14 Leren19
reported that the difference in all-cause mortality was
not statistically signiﬁcant (p=0.35). The total CHD mor-
tality was 79 out of 206 men in the diet group and 94
out of 206 men in the control group (p=0.097).
Woodhill et al20 recorded 39 deaths in the intervention
group and 28 in the control group. There were 35
deaths from CHD in the intervention group and 25 in
the control group. These were described as signiﬁcant,
but not endorsed by statistical analysis.
Serum cholesterol levels
Mean serum cholesterol levels fell in all groups: control
and intervention. The standardised mean difference in
serum cholesterol levels, for the six trials (seven inter-
ventions) combined, was −12.6%±6.7% for the interven-
tion groups and −6.5%±5.1% for the control groups
(table 1). The effect size was 1.04.
DISCUSSION
The main ﬁndings of the present meta-analysis of the six
RCTs available at the time of issuing dietary guidelines
in the US and UK indicate that all-cause mortality was
identical at 370 in the intervention and control groups.
There was no statistically signiﬁcant difference in deaths
from CHD. The reductions in mean serum cholesterol
levels were signiﬁcantly higher in the intervention
groups; this did not result in signiﬁcant differences in
CHD or all-cause mortality.
It is a widely held view that reductions in cholesterol are
healthful per se. The original RCTs did not ﬁnd any rela-
tionship between dietary fat intake and deaths from CHD
or all-causes, despite signiﬁcant reductions in cholesterol
levels in the intervention and control groups. This under-
mines the role of serum cholesterol levels as an intermedi-
ary to the development of CHD and contravenes the
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theory that reducing dietary fat generally and saturated fat
particularly potentiates a reduction in CHD.
There are some important design limitations among
the available RCTs. The LA Veterans study17 provided
meals in a contained environment, but was undermined
by open enrolment, allowing participants to leave and
join. The other ﬁve RCTs relied on dietary advice, with
meetings and periodical dietary analysis to monitor
adherence. Three of these studies audited outcomes
and the data extracted in table 1 recorded actual, not
target, dietary intake.14 19 20 A number of studies
impaired assessment of one intervention (administering
oils) by adding other dietary restrictions.16 17 19
The LA Veterans study17 recorded the lowest RR for
CHD deaths for the intervention group: 0.816 (ﬁgure
3). However, there were important differences in the
groups at study entry. The intervention group had 12
octogenarians, compared with 21 in the control group.
Eleven per cent of the experiment group were heavy
smokers (more than one pack a day) compared with
17% of the control group.
Woodhill et al20 made an important observation that
men who have suffered an myocardial infarction (MI)
subsequently make multiple lifestyle changes (weight
loss, smoking cessation, increase in physical activity, for
example), which makes them a poor group for testing
the lipid hypothesis. In this respect, the reporting of
cholesterol decreases in control and intervention groups
supports the observation that multiple lifestyle changes
are made.
Studies of the time report weight, not body mass.
Weight changes were not recorded in two studies.14 19
The two studies noted no signiﬁcant weight change in
intervention or control groups.16 17 The Research
Committee study15 reported mean weight loss as 7.5% in
the intervention group and 4.8% in the control group.
Woodhill et al20 reported a mean weight loss of 6.5%
and 6% in the intervention and control groups,
respectively.
The phytosterol content of vegetable oils could
explain reductions in cholesterol levels with no concomi-
tant reductions in deaths.27
A limitation of the present review and meta-analysis
relates to the detailed information in the original studies
in order to determine the saturated, monounsaturated
and polyunsaturated content of the control and inter-
vention diets. Woodhill et al20 was the only study to detail
the composition of the three fats in the intervention
and control diet; a 10% saturated fat intake being the
intervention goal. Leren19 documented the intervention
diet as 40% of total calories as fat; 8.3% of total calories
as saturated fat and a polyunsaturated to saturated fat
ratio of 2.4:1. No comparable measures were given for
the control diet in this study. Other studies recorded
total fat intake as a percentage of calories, but not indi-
vidual fat composition. Consequently, deductions about
the relationship between different fats and serum choles-
terol levels cannot be made.
Deductions can be made about the dietary interven-
tions and mortality from all-causes and CHD. The Rose
et al14 interventions most notably favour the control in
both forest plots, but the wide CIs render these, as with
all the studies, non-signiﬁcant.
Only one study made a positive claim for its intervention
after 5 years18 and subsequently, this was moderated.19
Rose et al14 warned of possible harm by administering corn
oil. The Research Committee15 concluded “A low-fat diet
has no place in the treatment of myocardial infarction”
(p504). The MRC Soya-bean oil16 intervention found no
evidence that MI relapse would be materially affected by
unsaturated fat in the diet. The LA Veterans study17
reported that total longevity was not affected and
expressed concern about unknown toxicity of their inter-
vention. Woodhill et al20 noted that survival was signiﬁ-
cantly better in the control than the diet group.
In the absence of epidemiological evidence from
whole-populations, large-scale RCTs of longer duration
(with adequate follow-up), which accounted for known
confounding variables and included primary partici-
pants of both males and females, may have supported
the introduction of dietary fat guidelines in 1977 and
1983. However, this opportunity expired when universal
pharmacological treatment became the accepted norm.
From the literature available, it is clear that at the time
dietary advice was introduced, 2467 men had been
observed in RCTs. No women had been studied; no
primary prevention study had been undertaken; no RCT
had tested the dietary fat recommendations; no RCT
concluded that dietary guidelines should be introduced.
It seems incomprehensible that dietary advice was intro-
duced for 220 million Americans28 and 56 million UK
citizens,29 given the contrary results from a small
number of unhealthy men.
An exchange between Dr Robert Olson of St Louis
University and Senator George McGovern, chair of the
Dietary Committee, was recorded in July 1977.30 Olson said
“I pleaded in my report and will plead again orally here for
more research on the problem before we make announce-
ments to the American public.” McGovern replied
“Senators don’t have the luxury that the research scientist
does of waiting until every last shred of evidence is in”.
There was best practice, randomised controlled trial,
evidence available to the dietary committees, which was
not considered and should have been. The results of the
present meta-analysis support the hypothesis that the
available RCTs did not support the introduction of
dietary fat recommendations in order to reduce CHD
risk or related mortality.
Two recent publications have questioned the alleged
relationship between saturated fat and CHD and called
for dietary guidelines to be reconsidered.31 32
The present review concludes that dietary advice not
merely needs review; it should not have been introduced.
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